Abstract
Medication adherence is critical for patients with bipolar disorder to avoid symptom exacerbation and diminished quality of life. Most analyses consider adherence barriers individually rather than conjointly, while neglecting potential ethnic differences. 435 patients in the Continuous Improvement for Veterans in Care––Mood Disorders study reported multiple financial and psychosocial factors influencing adherence. Logistic regression modeled adherence as a function of perceived barriers, including cost burden, access, binge drinking, poor therapeutic alliance, and medication beliefs. Nearly half the cohort experienced adherence difficulty, averaging 2.8 barriers, with minority veterans reporting lower adherence than white patients, particularly financial burden and treatment access. Total barriers were significantly associated with worse adherence (OR = 1.24 per barrier), notably poor medication beliefs, binge drinking, and difficulty accessing psychiatric specialists (ORs of 2.41, 1.95 and 1.73, respectively). Veterans with bipolar disorder experience numerous adherence barriers, with certain obstacles proving especially pernicious. Fortunately tailored clinical interventions can improve adherence, particularly by addressing modifiable risk factors.
Similar content being viewed by others
References
Bauer, M. S., McBride, L., Williford, W. O., Glick, H., Kinosian, B., Altshuler, L., et al. (2006). Collaborative care for bipolar disorder: Part II. Impact on clinical outcome, function, and costs. Psychiatric Service, 57(7), 937–945.
Bauer, M., Unutzer, J., Pincus, H. A., & Lawson, W. B. (2002). Bipolar disorder. Mental Health Service Research, 4(4), 225–229.
Blow, F. C., McCarthy, J. F., Valenstein, M., Austin, K., Kavanagh, J., & Gillon, L. (2005). Care for Veterans with Psychosis in the VHA, FY04: 6th Annual National Psychosis Registry. Ann Arbor: Veterans Affairs HSR&D.
Blow, F. C., Zeber, J. E., McCarthy, J. F., Valenstein, M., Gillon, L., & Bingham, C. R. (2004). Ethnicity and diagnostic patterns in veterans with psychoses. Social Psychiatry and Psychiatric Epidemiology, 39(10), 841–851.
Clatworthy, J., Bowskill, R., Rank, T., Parham, R., & Horne, R. (2007). Adherence to medication in bipolar disorder: A qualitative study exploring the role of patients’ beliefs about the condition and its treatment. Bipolar Disorders, 9(6), 656–664.
Cobaugh, D. J., Angner, E., Kiefe, C. I., Ray, M. N., Lacivita, C. L., Weissman, N. W., et al. (2008). Effect of racial differences on ability to afford prescription medications. American Journal of Health System Pharmacy, 65(22), 2137–2143.
Colom, F., & Lam, D. (2005). Psychoeducation: Improving outcomes in bipolar disorder. European Psychiatry, 20(5–6), 359–364.
Copeland, L. A., Zeber, J. E., Salloum, I. M., Pincus, H. A., Fine, M. J., & Kilbourne, A. M. (2008). Treatment adherence and illness insight in veterans with bipolar disorder. Journal of Nervous and Mental Disease, 196(1), 16–21.
Cunningham, W. E., Hays, R. D., Williams, K. W., Beck, K. C., Dixon, W. J., & Shapiro, M. F. (1995). Access to medical care and health-related quality of life for low-income persons with symptomatic human immunodeficiency virus. Medical Care, 33(7), 739–754.
Dennehy, E. B., Suppes, T., Rush, A. J., Miller, A. L., Trivedi, M. H., Crismon, M. L., et al. (2005). Does provider adherence to a treatment guideline change clinical outcomes for patients with bipolar disorder? Results from the Texas Medication Algorithm Project. Psychological Medicine, 35(12), 1695–1706.
Fleck, D. E., Keck, P. E., Jr., Corey, K. B., & Strakowski, S. M. (2005). Factors associated with medication adherence in African American and white patients with bipolar disorder. Journal of Clinical Psychiatry, 66(5), 646–652.
Fortney, J. C., Pyne, J. M., Edlund, M. J., Williams, D. K., Robinson, D. E., Mittal, D., et al. (2007). A randomized trial of telemedicine-based collaborative care for depression. Journal of General Internal Medicine, 22(8), 1086–1093.
Gallo, J. J., Meredith, L. S., Gonzales, J., Cooper, L. A., Nutting, P., Ford, D. E., et al. (2002). Do family physicians and internists differ in knowledge, attitudes, and self-reported approaches for depression? International Journal of Psychiatry in Medicine, 32(1), 1–20.
Gaudiano, B. A., Weinstock, L. M., & Miller, I. W. (2008). Improving treatment adherence in bipolar disorder: A review of current psychosocial treatment efficacy and recommendations for future treatment development. Behavior Modification, 32(3), 267–301.
George, C. F., Peveler, R. C., Heiliger, S., & Thompson, C. (2000). Compliance with tricyclic antidepressants: The value of four different methods of assessment. British Journal of Clinical Pharmacology, 50(2), 166–171.
Glick, H. A., McBride, L., & Bauer, M. S. (2003). A manic-depressive symptom self-report in optical scanable format. Bipolar Disorders, 5(5), 366–369.
Goldberg, R. W., Green-Paden, L. D., Lehman, A. F., & Gold, J. M. (2001). Correlates of insight in serious mental illness. Journal of Nervous and Mental Disease, 189(3), 137–145.
Gonzalez, J. M., Alegria, M., Prihoda, T. J., Copeland, L. A., & Zeber, J. E. (2010). How attitudes toward mental health treatment and service use differ by age, gender, ethnicity/race and education. Social Psychiatry and Psychiatric Epidemiology (in press).
Guo, J. J., Keck, P. E., Li, H., & Patel, N. C. (2007). Treatment costs related to bipolar disorder and comorbid conditions among Medicaid patients with bipolar disorder. Psychiatric Services, 58(8), 1073–1078.
Hassan, M., Madhavan, S., Kalsekar, I., Makela, E., Rajagopalan, K., Islam, S., et al. (2007). Comparing adherence to and persistence with antipsychotic therapy among patients with bipolar disorder. Annals of Pharmacotherapy, 41(11), 1812–1818.
Havens, L. L., & Ghaemi, S. N. (2005). Existential despair and bipolar disorder: The therapeutic alliance as a mood stabilizer. American Journal of Psychotherapy, 59(2), 137–147.
Johnson, F. R., Ozdemir, S., Manjunath, R., Hauber, A. B., Burch, S. P., & Thompson, T. R. (2007). Factors that affect adherence to bipolar disorder treatments: A stated-preference approach. Medical Care, 45(6), 545–552.
Keck, P. E., Jr., McElroy, S. L., Strakowski, S. M., Bourne, M. L., & West, S. A. (1997). Compliance with maintenance treatment in bipolar disorder. Psychopharmacology Bulletin, 33(1), 87–91.
Kessler, R. C., Berglund, P. A., Bruce, M. L., Koch, J. R., Laska, E. M., Leaf, P. J., et al. (2001). The prevalence and correlates of untreated serious mental illness. Health Services Research, 36(6 Pt 1), 987–1007.
Kilbourne, A. M. (2005). The burden of general medical conditions in patients with bipolar disorder. Current Psychiatry Reports, 7(6), 471–477.
Kilbourne, A. M., Bauer, M. S., Pincus, H., Williford, W. O., Kirk, G. F., & Beresford, T. (2005a). Clinical, psychosocial, and treatment differences in minority patients with bipolar disorder. Bipolar Disorders, 7(1), 89–97.
Kilbourne, A. M., Good, C. B., Sereika, S. M., Justice, A. C., & Fine, M. J. (2005b). Algorithm for assessing patients’ adherence to oral hypoglycemic medication. American Journal of Health System Pharmacy, 62(2), 198–204.
Kilbourne, A. M., Lasky, E., Pincus, H. A., Good, C. B., Cooley, S., Basavaraju, A., et al. (2008a). The continuous improvement for veterans in care: Mood Disorders (civic-md) Study, a VA-academic partnership. Psychiatric Services, 59(5), 483–485.
Kilbourne, A. M., Post, E. P., Nossek, A., Drill, L., Cooley, S., & Bauer, M. S. (2008b). Improving medical and psychiatric outcomes among individuals with bipolar disorder: A randomized controlled trial. Psychiatric Services, 59(7), 760–768.
Kogan, J. N., Otto, M. W., Bauer, M. S., Dennehy, E. B., Miklowitz, D. J., Zhang, H. W., et al. (2004). Demographic and diagnostic characteristics of the first 1000 patients enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Bipolar Disorders, 6(6), 460–469.
Lew, K. H., Chang, E. Y., Rajagopalan, K., & Knoth, R. L. (2006). The effect of medication adherence on health care utilization in bipolar disorder. Managed Care Interface, 19(9), 41–46.
Lingam, R., & Scott, J. (2002). Treatment non-adherence in affective disorders. Acta Psychiatrica Scandinavica, 105(3), 164–172.
Ludman, E. J., Simon, G. E., Rutter, C. M., Bauer, M. S., & Unutzer, J. (2002). A measure for assessing patient perception of provider support for self-management of bipolar disorder. Bipolar Disorders, 4(4), 249–253.
Maciejewski, M. L., Bryson, C. L., Perkins, M., Blough, D. K., Cunningham, F. E., Fortney, J. C., et al. (2010). Increasing copayments and adherence to diabetes, hypertension, and hyperlipidemic medications. The American Journal of Managed Care, 16(1), e20–e34.
Manwani, S. G., Szilagyi, K. A., Zablotsky, B., Hennen, J., Griffin, M. L., & Weiss, R. D. (2007). Adherence to pharmacotherapy in bipolar disorder patients with and without co-occurring substance use disorders. Journal of Clinical Psychiatry, 68(8), 1172–1176.
Marangell, L. B. (2008). Current issues: Women and bipolar disorder. Dialogues in Clinical Neuroscience, 10(2), 229–238.
Martinez-Aran, A., Scott, J., Colom, F., Torrent, C., Tabares-Seisdedos, R., Daban, C., et al. (2009). Treatment nonadherence and neurocognitive impairment in bipolar disorder. The Journal of Clinical Psychiatry, 70, 1017–1023.
McCarthy, J. F., Blow, F. C., Valenstein, M., Fischer, E. P., Owen, R. R., Barry, K. L., et al. (2007). Veterans Affairs Health System and mental health treatment retention among patients with serious mental illness: Evaluating accessibility and availability barriers. Health Services Research, 42(3 Pt 1), 1042–1060.
Miller, I. W., Uebelacker, L. A., Keitner, G. I., Ryan, C. E., & Solomon, D. A. (2004). Longitudinal course of bipolar I disorder. Comprehensive Psychiatry, 45(6), 431–440.
Morisky, D. E., Green, L. W., & Levine, D. M. (1986). Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care, 24(1), 67–74.
Murray, C. J., & Lopez, A. D. (1996). Evidence-based health policy-lessons from the Global Burden of Disease Study. Science, 274(5288), 740–743.
Piette, J. D., & Heisler, M. (2004). Problems due to medication costs among VA and non-VA patients with chronic illnesses. The American Journal of Managed Care, 10(11 Pt 2), 861–868.
Piette, J. D., Heisler, M., Krein, S., & Kerr, E. A. (2005). The role of patient-physician trust in moderating medication nonadherence due to cost pressures. Archives of Internal Medicine, 165(15), 1749–1755.
Post, R. M., Denicoff, K. D., Leverich, G. S., Altshuler, L. L., Frye, M. A., Suppes, T. M., et al. (2003). Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. Journal of Clinical Psychiatry, 64(6), 680–690. quiz 689–738.
Saha, S., Freeman, M., Toure, J., Tippens, K. M., Weeks, C., & Ibrahim, S. (2008). Racial and ethnic disparities in the VA health care system: A systematic review. Journal of General Internal Medicine, 23(5), 654–671.
Sajatovic, M., Blow, F. C., Kales, H. C., Valenstein, M., Ganoczy, D., & Ignacio, R. V. (2007). Age comparison of treatment adherence with antipsychotic medications among individuals with bipolar disorder. International Journal of Geriatric Psychiatry, 22(10), 992–998.
Sajatovic, M., Davies, M., Bauer, M. S., McBride, L., Hays, R. W., Safavi, R., et al. (2005). Attitudes regarding the collaborative practice model and treatment adherence among individuals with bipolar disorder. Comprehensive Psychiatry, 46(4), 272–277.
Sajatovic, M., Ignacio, R. V., West, J. A., Cassidy, K. A., Safavi, R., Kilbourne, A. M., et al. (2009). Predictors of nonadherence among individuals with bipolar disorder receiving treatment in a community mental health clinic. Comprehensive Psychiatry, 50(2), 100–107.
Saunders, J. B., Aasland, O. G., Babor, T. F., de la Fuente, J. R., & Grant, M. (1993). Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption–II. Addiction, 88(6), 791–804.
Scott, J. (2002). Using Health Belief Models to understand the efficacy-effectiveness gap for mood stabilizer treatments. Neuropsychobiology, 46 Suppl 1, 13–15.
Scott, J., & Pope, M. (2002). Nonadherence with mood stabilizers: Prevalence and predictors. Journal of Clinical Psychiatry, 63(5), 384–390.
Stender, M., Bryant-Comstock, L., & Phillips, S. (2002). Medical resource use among patients treated for bipolar disorder: A retrospective, cross-sectional, descriptive analysis. Clinical Therapeutics, 24(10), 1668–1676.
Strauss, J. L., & Johnson, S. L. (2006). Role of treatment alliance in the clinical management of bipolar disorder: Stronger alliances prospectively predict fewer manic symptoms. Psychiatry Research, 145(2–3), 215–223.
Stroupe, K. T., Smith, B. M., Lee, T. A., Tarlov, E., Durazo-Arvizu, R., Huo, Z., et al. (2007). Effect of increased copayments on pharmacy use in the Department of Veterans Affairs. Medical Care, 45(11), 1090–1097.
Svarstad, B. L., Shireman, T. I., & Sweeney, J. K. (2001). Using drug claims data to assess the relationship of medication adherence with hospitalization and costs. Psychiatric Services, 52(6), 805–811.
Taj, F., Tanwir, M., Aly, Z., Khowajah, A. A., Tariq, A., Syed, F. K., et al. (2008). Factors associated with non-adherence among psychiatric patients at a tertiary care hospital, Karachi, Pakistan: A questionnaire based cross-sectional study. Journal of the Pakistan Medical Association, 58(8), 432–436.
Tonigan, J. S. (2003). Project Match treatment participation and outcome by self-reported ethnicity. Alcoholism, Clinical and Experimental Research, 27(8), 1340–1344.
Valenstein, M., Blow, F. C., Copeland, L. A., McCarthy, J. F., Zeber, J. E., Gillon, L., et al. (2004). Poor antipsychotic adherence among patients with schizophrenia: Medication and patient factors. Schizophrenia Bulletin, 30(2), 255–264.
Velligan, D. I., Diamond, P. M., Mintz, J., Maples, N., Li, X., Zeber, J., et al. (2008). The use of individually tailored environmental supports to improve medication adherence and outcomes in schizophrenia. Schizophrenia Bulletin, 34(3), 483–493.
Weiden, P. J., & Rao, N. (2005). Teaching medication compliance to psychiatric residents: Placing an orphan topic into a training curriculum. Academic Psychiatry, 29(2), 203–210.
Yen, C. F., Lee, Y., Tang, T. C., Yen, J. Y., Ko, C. H., & Chen, C. C. (2009). Predictive value of self-stigma, insight, and perceived adverse effects of medication for the clinical outcomes in patients with depressive disorders. Journal of Nervous and Mental Disease, 197(3), 172–177.
Yerevanian, B. I., Koek, R. J., & Mintz, J. (2007). Bipolar pharmacotherapy and suicidal behavior. Part I: Lithium, divalproex and carbamazepine. Journal of Affective Disorders, 103(1–3), 5–11.
Zeber, J. E., Copeland, L. A., Good, C. B., Fine, M. J., Bauer, M. S., & Kilbourne, A. M. (2008a). Therapeutic alliance perceptions and medication adherence in patients with bipolar disorder. Journal of Affective Disorders, 107(1–3), 53–62.
Zeber, J.E, Copeland, L.A, Miller, A. L., Kilbourne, A.M., Velligan, D., & Mortensen, E. (2008b). Ethnicity and the impact of higher medication copayments among veterans with schizophrenia. [abstract presented at the 2008 Critical Research Issues in Latino Mental Health Conference, Santa Fe, NM].
Zeber, J. E., Grazier, K. L., Valenstein, M., Blow, F. C., & Lantz, P. M. (2007). Effect of a medication copayment increase in veterans with schizophrenia. The American Journal of Managed Care, 13(6 Pt 2), 335–346.
Acknowledgments
Funding for this study was provided by the Department of Veterans Affairs, Health Services Research and Development Service (Merit Review IIR 02-283-2, MREP Career Development Award HSR&D 02269).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zeber, J.E., Miller, A.L., Copeland, L.A. et al. Medication Adherence, Ethnicity, and the Influence of Multiple Psychosocial and Financial Barriers. Adm Policy Ment Health 38, 86–95 (2011). https://doi.org/10.1007/s10488-010-0304-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10488-010-0304-1